Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on β-cell rest?

Journal of Autoimmunity

Volumn 9, Issue 3, 1996, Pages 341-348

  Jansen, Annemarie ^c   Rosmalen, Judith G M ^c   Homo Delarche, Françoise ^a   Dardenne, Mireille ^a   Drexhage, Hemmo A ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c NONE

Author keywords

Diabetes; Insulin prophylaxis; Macrophages; Mega islets; NOD

Indexed keywords

INSULIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0013522709     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0046     Document Type: Conference Paper

References (37)

1. 1. Powers A.C., Eisenbarth G.S. 1985. Autoimmunity to islet cells in diabetes mellitus. Annu. Rev. Med. 36: 533-544
2. 2. Bach J.F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 15: 516-542
3. 3. Malone J.I., Shah S.C. 1993. The role of exogenous insulin in the pathogenesis of autoimmune diabetes mellitus. Pediatr. Adolesc. Endocrinol 23: 135-139
4. 4. Agner T., Damm P., Binder C. 1987. Remission in IDDM: Prospective study of basal c-peptide and insulin dose in 268 consecutive patients. Diabetes Care 10: 164-169
5. 5. Shah S.C., Malone J.I., Simpson N.E. 1989. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New Eng. J. Med. 320: 550-554
6. 6. Malone J.I., MacLaren N.K., Riley W., Spillar R. 1991. High dose insulin therapy (HDIT) resulted in long term survival of beta cells and disappearance of islet cell antibodies (ICA) in IDDM. Diabetes 40: 152A
7. 7. Keller R.J., Eisenbarth G.S., Jackson R.A. 1993. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341: 927-928
8. 8. Ziegler A.-G., Bachmann W., Rabi W. 1993. Prophylactic insulin treatment in relatives at high risk for type 1 diabetes. Diabetes Metab. Rev. 9: 289-293
9. 9. Portha B., Picon L. 1982. Insulin treatment improves the spontaneous remission of neonatal streptozotocin diabetes in the rat. Diabetes 31: 165-169
10. 10. Gotfredsen C.F., Buschard K., Frandsen E.K. 1985. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28: 933-935
11. 11. Gottlieb P.A., Handler E.S., Appel M.C., Greiner D.L., Mordes J.P., Rossini A.A. 1991. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats. Diabetologia 34: 296-300
12. 12. Vlahos W.D., Seemayer T.A., Yale J.-F. 1991. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 40: 825-829
13. 13. Atkinson M.A., Maclaren N.K., Luchetta R. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933-937
14. 14. Thivolet C.H., Goillot E., Bedossa P., Durand A., Bonnard M., Orgiazzi J. 1991. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 34: 314-319
15. 15. Bertrand S., Paepe M., Vigeant C., Yale J.-F. 1992. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 41: 1273-1277
16. 16. Hunt U., Eardley D.D. 1986. Suppressive effects of insulin and insulin like growth factor 1 (IGF-1) on immune responses. J. Immunol. 136: 3994-3999
17. 17. Argoud G.M., Schade D.S., Eaton R.P. 1987. Insulin suppresses its own secretion in vivo. Diabetes 36: 959-962
18. 18. Appel M.C., Dotta F., O'Neil J., Eisenbarth G.S. 1989. Beta cell activity regulates the expression of islet antigenic determinants. Diabetologia 32: 461A
19. 19. Lee K.U., Amano K., Yoon J.W. 1988. Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989-991
20. 20. Voorbij H.A.M., Jeucken P.H.M., Kabel P.J., de Haan M., Drexhage H.A. 1989. Dendritic cells and scavenger macrophages in pancreatic islets of prediabetic BB rats. Diabetes 38: 1623-1629
21. 21. Ihm S.H., Yoon J.W. 1990. Studies on autoimmunity for initiation of β-cell destruction. VI. Macrophages essential for development of β-cell specific cytotoxic effects and insulitis in NOD mice. Diabetes 39: 1273-1278
22. 22. Jansen A., Homo-Delarche F., Hooijkaas H., Leenen P.J., Dardenne M., Drexhage H.A. 1994. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β-cell destruction in NOD mice. Diabetes 43: 667-675
23. 23. Kraal G., Janse M. 1986. Marginal metallophylic macrophages of the mouse spleen identified by a monoclonal antibody. Immunology 58: 665-669
24. 24. Kraal G., Janse M., Claassen E. 1988. Marginal metallophylic macrophages in the mouse spleen: effects of neonatal injection of MOMA-1 antibody on the humoral immune response. Immunol. Lett. 17: 139-144
25. 25. Aaen K., Rygaard J., Josefsen K., Petersen H., Brogren C.-H., Horn T., Buschard K. 1990. Dependence of antigen expression on functional state of β-cells. Diabetes 39: 697-701
26. 26. Fitzpatrick F., Lepault F., Homo-Delarche F., Bach J.-F., Dardenne M. 1991. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. Endocrinology 129: 1382-1390
27. 27. Allaerts W., Carmeliet P., Denef C. 1990. New perspectives in the function of pituitary folliculo-stellate cells. Mol. Cell. Endocrinol. 71: 73-81
28. 28. Kokia E., Hurwitz A., Ricciarelli E., Tedeschi E., Resnick C., Mitchell M., Adashi E.Y. 1992. Interleukin-1 stimulates ovarian prostaglandin biosynthesis: evidence for cell-cell interaction. Endocrinology 130: 3095-3097
29. 29. Gaytan F., Bellido C., Aguilar E., van Rooijen. 1995. Pituitary testicular axis in rats lacking testicular macrophages. Eur. J. Endocrinol. 132: 218-222
30. 30. Kirsch T.M., Friedman A.C., Vogel R.L., Flickeringer G.L. 1981. Macrophages in corporea lutea of mice: characterization and effects on steroid secretion. Biol. Reprod. 25: 629-638
31. 31. Halme J., Hammond M.G., Syrap C.H., Talbert L.M. 1985. Peritoneal macrophages modulate human granulosa-luteal progesterone production. J. Clin. Endocrinol. Metab. 61: 912-916
32. 32. Chick W.L., Warren S., Chute R.N., Like A.A., Lauris V., Kitchen K.C. 1977. A transplantable insulinoma in the rat. Proc. Natl. Acad. Sci. USA 74: 628-632
33. 33. Buschard K. 1991. The functional state of the beta cells in the pathogenesis of insulin-dependent diabetes mellitus. Autoimmunity 10: 65-69
34. 34. Palmer J.P., Helqvist S., Spinas G.A., Mølvig J., Mandrup-Poulsen T., Andersen H.U., Nerup J. 1989. Interaction of β-cell activity and II-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38: 1211-1216
35. 35. Vlahos W.D., Yale J.-F. 1987. Prevention of type I diabetes in the BB rat by diazoxide. Clin. Invest. Med. 10: B65
36. 36. Strubbe J.H., Steffens A.B. 1993. Neural control of insulin secretion. Horm. Metab. Res. 25: 507-512
37. 37. Boden G., Chen X., DeSantis R., Kolaczynski J., Morris M. 1993. Evidence that suppression of insulin secretion by insulin itself is neurally mediated. Metabolism 42: 786-789